Danish educational materials

02 February 2023

From November 15th 2016 the Danish Medicines Agency published Danish educational materials for human medicinal products approved via the national procedure, the mutual recognition procedure and the decentralised procedure.

From January 1st 2023 and forward – and not retroactively - the Danish Medicines Agency also publishes Danish educational materials for human medicinal products approved via the centralised procedure.

The marketing authorisation holder has the overall responsibility for the educational material and for ensuring that it complies with the conditions of the marketing authorisation. The marketing authorisation holder also has the overall responsibility for ensuring that the Danish Medicines Agency has the latest accepted written educational material available for publication.

Please refer to the section Dansk uddannelsesmateriale for the accepted and published Danish educational materials 

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å 0-9
Ea-Ed Ee-Eh Ei-El Em-Ep Eq-Eu Ev-Ez Eæ-Eå
Name Medicine Type Strength Active substance Mft owner Publish Date
Exjade filmovertrukne tabletter 90 mg Deferasirox Novartis Europharm Limited 08/03/2023
Exjade filmovertrukne tabletter 180 mg Deferasirox Novartis Europharm Limited 08/03/2023
Exjade filmovertrukne tabletter 360 mg Deferasirox Novartis Europharm Limited 08/03/2023
Extraneal peritonealdialysevæske 75 mg/ml ICODEXTRIN Vantive ApS 14/08/2020
Eylea injektionsvæske, opløsning 40 mg/ml Aflibercept Bayer AG 11/10/2024
Eylea injektionsvæske, opløsning 114,3 mg/ml Aflibercept Bayer AG 11/10/2024
Eylea injektionsvæske, opløsning i fyldt injektionssprøjte 114,3 mg/ml Aflibercept Bayer AG 11/10/2024
Eylea injektionsvæske, opløsning i fyldt injektionssprøjte 40 mg/ml Aflibercept Bayer AG 09/02/2024